These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1733803)
1. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Odetti P; Fogarty J; Sell DR; Monnier VM Diabetes; 1992 Feb; 41(2):153-9. PubMed ID: 1733803 [TBL] [Abstract][Full Text] [Related]
2. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia. Miyata T; Ueda Y; Yamada Y; Izuhara Y; Wada T; Jadoul M; Saito A; Kurokawa K; van Ypersele de Strihou C J Am Soc Nephrol; 1998 Dec; 9(12):2349-56. PubMed ID: 9848790 [TBL] [Abstract][Full Text] [Related]
3. ELISA of pentosidine, an advanced glycation end product, in biological specimens. Taneda S; Monnier VM Clin Chem; 1994 Sep; 40(9):1766-73. PubMed ID: 8070089 [TBL] [Abstract][Full Text] [Related]
4. Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Sell DR; Nagaraj RH; Grandhee SK; Odetti P; Lapolla A; Fogarty J; Monnier VM Diabetes Metab Rev; 1991 Dec; 7(4):239-51. PubMed ID: 1813279 [TBL] [Abstract][Full Text] [Related]
5. Quantification of the cross-link pentosidine in serum from normal and uremic subjects. Takahashi M; Kushida K; Kawana K; Ishihara C; Denda M; Inoue T; Horiuchi K Clin Chem; 1993 Oct; 39(10):2162-5. PubMed ID: 8403403 [TBL] [Abstract][Full Text] [Related]
6. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872 [TBL] [Abstract][Full Text] [Related]
8. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia. Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192 [TBL] [Abstract][Full Text] [Related]
9. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546 [TBL] [Abstract][Full Text] [Related]
10. Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography. Floridi A; Trizza V; Paolotti P; Lucarelli C J Chromatogr A; 1999 Jun; 846(1-2):65-71. PubMed ID: 10420599 [TBL] [Abstract][Full Text] [Related]
11. Plasma pentosidine levels in uremic patients before and after hemodialysis. Takahashi M; Kushida K; Ishihara C; Denda M; Inoue T Scand J Urol Nephrol; 1995 Jun; 29(2):131-4. PubMed ID: 7569788 [TBL] [Abstract][Full Text] [Related]
12. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product. Miyazaki K; Nagai R; Horiuchi S J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068 [TBL] [Abstract][Full Text] [Related]
13. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. Miyata T; Ueda Y; Shinzato T; Iida Y; Tanaka S; Kurokawa K; van Ypersele de Strihou C; Maeda K J Am Soc Nephrol; 1996 Aug; 7(8):1198-206. PubMed ID: 8866413 [TBL] [Abstract][Full Text] [Related]
14. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment. Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940 [TBL] [Abstract][Full Text] [Related]
15. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Monnier VM; Sell DR; Nagaraj RH; Miyata S; Grandhee S; Odetti P; Ibrahim SA Diabetes; 1992 Oct; 41 Suppl 2():36-41. PubMed ID: 1526333 [TBL] [Abstract][Full Text] [Related]
16. Direct quantification of pentosidine in urine and serum by HPLC with column switching. Takahashi M; Hoshino H; Kushida K; Kawana K; Inoue T Clin Chem; 1996 Sep; 42(9):1439-44. PubMed ID: 8787701 [TBL] [Abstract][Full Text] [Related]
17. The advanced glycation endproduct pentosidine and monocyte activation in uremia. Friedlander MA; Witko-Sarsat V; Nguyen AT; Wu YC; Labrunte M; Verger C; Jungers P; Descamps-Latscha B Clin Nephrol; 1996 Jun; 45(6):379-82. PubMed ID: 8793229 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms for the formation of glycoxidation products in end-stage renal disease. Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627 [TBL] [Abstract][Full Text] [Related]
19. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress". Jadoul M; Ueda Y; Yasuda Y; Saito A; Robert A; Ishida N; Kurokawa K; Van Ypersele De Strihou C; Miyata T Kidney Int; 1999 Jun; 55(6):2487-92. PubMed ID: 10354298 [TBL] [Abstract][Full Text] [Related]
20. Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection. Scheijen JL; van de Waarenburg MP; Stehouwer CD; Schalkwijk CG J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(7):610-4. PubMed ID: 19188098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]